vs

Side-by-side financial comparison of FIRST UNITED CORP (FUNC) and X4 Pharmaceuticals, Inc (XFOR). Click either name above to swap in a different company.

X4 Pharmaceuticals, Inc is the larger business by last-quarter revenue ($28.8M vs $23.2M, roughly 1.2× FIRST UNITED CORP). FIRST UNITED CORP runs the higher net margin — 24.9% vs 1.0%, a 23.9% gap on every dollar of revenue.

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

X4 Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel targeted therapies for rare immunological diseases and oncology indications with high unmet medical needs. It operates primarily across the U.S. and European markets, with a lead pipeline candidate for WHIM syndrome and multiple other preclinical and clinical assets for immune disorders and cancer.

FUNC vs XFOR — Head-to-Head

Bigger by revenue
XFOR
XFOR
1.2× larger
XFOR
$28.8M
$23.2M
FUNC
Higher net margin
FUNC
FUNC
23.9% more per $
FUNC
24.9%
1.0%
XFOR

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
FUNC
FUNC
XFOR
XFOR
Revenue
$23.2M
$28.8M
Net Profit
$5.8M
$282.0K
Gross Margin
83.6%
Operating Margin
32.9%
-32.8%
Net Margin
24.9%
1.0%
Revenue YoY
11.9%
Net Profit YoY
-6.6%
100.5%
EPS (diluted)
$0.89
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUNC
FUNC
XFOR
XFOR
Q4 25
$23.2M
Q3 25
$22.7M
Q2 25
$21.8M
Q1 25
$20.9M
$28.8M
Q4 24
$20.8M
Q3 24
$20.3M
Q2 24
$20.1M
Q1 24
$18.7M
$0
Net Profit
FUNC
FUNC
XFOR
XFOR
Q4 25
$5.8M
Q3 25
$6.9M
Q2 25
$6.0M
Q1 25
$5.8M
$282.0K
Q4 24
$6.2M
Q3 24
$5.8M
Q2 24
$4.9M
Q1 24
$3.7M
$-51.8M
Gross Margin
FUNC
FUNC
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
83.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
FUNC
FUNC
XFOR
XFOR
Q4 25
32.9%
Q3 25
40.6%
Q2 25
36.5%
Q1 25
36.8%
-32.8%
Q4 24
39.2%
Q3 24
38.0%
Q2 24
32.5%
Q1 24
26.0%
Net Margin
FUNC
FUNC
XFOR
XFOR
Q4 25
24.9%
Q3 25
30.6%
Q2 25
27.5%
Q1 25
27.7%
1.0%
Q4 24
29.8%
Q3 24
28.5%
Q2 24
24.5%
Q1 24
19.8%
EPS (diluted)
FUNC
FUNC
XFOR
XFOR
Q4 25
$0.89
Q3 25
$1.07
Q2 25
$0.92
Q1 25
$0.89
$0.04
Q4 24
$0.95
Q3 24
$0.89
Q2 24
$0.75
Q1 24
$0.56
$-7.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUNC
FUNC
XFOR
XFOR
Cash + ST InvestmentsLiquidity on hand
$131.6M
$40.3M
Total DebtLower is stronger
$95.9M
$75.0M
Stockholders' EquityBook value
$203.6M
$22.9M
Total Assets
$2.1B
$130.0M
Debt / EquityLower = less leverage
0.47×
3.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUNC
FUNC
XFOR
XFOR
Q4 25
$131.6M
Q3 25
$95.2M
Q2 25
$79.1M
Q1 25
$84.4M
$40.3M
Q4 24
$78.3M
Q3 24
$62.4M
Q2 24
$45.1M
Q1 24
$86.9M
$60.5M
Total Debt
FUNC
FUNC
XFOR
XFOR
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$120.9M
Q1 25
$120.9M
$75.0M
Q4 24
$120.9M
Q3 24
$120.9M
Q2 24
$70.9M
Q1 24
$70.9M
$55.0M
Stockholders' Equity
FUNC
FUNC
XFOR
XFOR
Q4 25
$203.6M
Q3 25
$199.1M
Q2 25
$191.1M
Q1 25
$183.7M
$22.9M
Q4 24
$179.3M
Q3 24
$174.0M
Q2 24
$164.2M
Q1 24
$165.5M
$1.0M
Total Assets
FUNC
FUNC
XFOR
XFOR
Q4 25
$2.1B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
$130.0M
Q4 24
$2.0B
Q3 24
$1.9B
Q2 24
$1.9B
Q1 24
$1.9B
$112.2M
Debt / Equity
FUNC
FUNC
XFOR
XFOR
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
3.27×
Q4 24
0.67×
Q3 24
0.70×
Q2 24
0.43×
Q1 24
0.43×
53.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUNC
FUNC
XFOR
XFOR
Operating Cash FlowLast quarter
$19.4M
$-12.4M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
66.3%
Capex IntensityCapex / Revenue
17.1%
0.0%
Cash ConversionOCF / Net Profit
3.35×
-43.86×
TTM Free Cash FlowTrailing 4 quarters
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUNC
FUNC
XFOR
XFOR
Q4 25
$19.4M
Q3 25
$1.5M
Q2 25
$995.0K
Q1 25
$7.0M
$-12.4M
Q4 24
$22.3M
Q3 24
$2.3M
Q2 24
$7.2M
Q1 24
$3.6M
$-33.6M
Free Cash Flow
FUNC
FUNC
XFOR
XFOR
Q4 25
$15.4M
Q3 25
$168.0K
Q2 25
$706.0K
Q1 25
$6.4M
Q4 24
$20.4M
Q3 24
$588.0K
Q2 24
$7.0M
Q1 24
$3.5M
$-33.7M
FCF Margin
FUNC
FUNC
XFOR
XFOR
Q4 25
66.3%
Q3 25
0.7%
Q2 25
3.2%
Q1 25
30.5%
Q4 24
98.1%
Q3 24
2.9%
Q2 24
35.1%
Q1 24
18.9%
Capex Intensity
FUNC
FUNC
XFOR
XFOR
Q4 25
17.1%
Q3 25
5.9%
Q2 25
1.3%
Q1 25
2.8%
0.0%
Q4 24
9.3%
Q3 24
8.4%
Q2 24
0.6%
Q1 24
0.3%
Cash Conversion
FUNC
FUNC
XFOR
XFOR
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
-43.86×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
1.46×
Q1 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

XFOR
XFOR

Segment breakdown not available.

Related Comparisons